The extracellular matrix of the central nervous system: Chondroitin sulphate type proteoglycans and neural repair

被引:4
作者
Crespo-Santiago, D [1 ]
机构
[1] Univ Cantabria, Fac Med, Dept Anat & Biol Celular, E-39011 Santander, Spain
关键词
central nervous system; chondroitin sulphate; chondroitinase; extracellular matrix; proteoglycans; regeneration;
D O I
10.33588/rn.3809.2003493
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aim. In this paper we present a review of the main features of the extracellular matrix (ECM) of the central nervous system (CNS). Development. Proteoglycans (PG) are glycoproteins, a very common type of protein in the ECM. Among the PG, the most abundant type is the hyalectan or lectican family. The PG is formed by two main components; a protein and a sugar chain, which that is termed glycosaminoglycan (GAG). These GAGs are polymers of two simple sugars. The hyalectan family has GAGs of the Chondroitin sulphate type (CS), and for this reason they are termed PG-CS. PG-CS are linked to the hyaluronic acid (HA) and other molecules of the ECM in order to form a three-dimensional network. This network has several important roles in the maintenance of the homeostasis of the CNS. Conclusions. Several hypotheses have been proposed to elucidate the failure of the CNS regeneration after an injury or in several pathologies. It has been suggested that PG-CS, which expression is up-regulated after CNS injury, may play some role in this process of inhibition of the CNS regeneration. Furthermore, we present an approach to the therapeutic potential of the CNS regeneration after the inactivation of the PG-CS up-regulation.
引用
收藏
页码:843 / 851
页数:9
相关论文
共 78 条
  • [1] Morphological domains of Lewis-X/FORSE-1 immunolabeling in the embryonic neural tube are due to developmental regulation of cell surface carbohydrate expression
    Allendoerfer, KL
    Durairaj, A
    Matthews, GA
    Patterson, PH
    [J]. DEVELOPMENTAL BIOLOGY, 1999, 211 (02) : 208 - 219
  • [2] Asher RA, 2000, J NEUROSCI, V20, P2427
  • [3] Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells
    Asher, RA
    Morgenstern, DA
    Shearer, MC
    Adcock, KH
    Pesheva, P
    Fawcett, JW
    [J]. JOURNAL OF NEUROSCIENCE, 2002, 22 (06) : 2225 - 2236
  • [4] ON THE EXISTENCE OF A CARTILAGE-LIKE PROTEOGLYCAN AND LINK PROTEINS IN THE CENTRAL-NERVOUS-SYSTEM
    ASHER, RA
    SCHEIBE, RJ
    KEISER, HD
    BIGNAMI, A
    [J]. GLIA, 1995, 13 (04) : 294 - 308
  • [5] Proteoglycans in the developing brain: New conceptual insights for old proteins
    Bandtlow, CE
    Zimmermann, DR
    [J]. PHYSIOLOGICAL REVIEWS, 2000, 80 (04) : 1267 - 1290
  • [6] Regulation of APP expression, biogenesis and metabolism by extracellular matrix and cytokines
    Beyreuther, K
    Multhaup, G
    Monning, U
    Sandbrink, R
    Beher, D
    Hesse, L
    Small, DH
    Masters, CL
    [J]. NEUROBIOLOGY OF ALZHEIMER'S DISEASE, 1996, 777 : 74 - 76
  • [7] Distribution of the large aggregating proteoglycan versican in adult human tissues
    BodeLesniewska, B
    DoursZimmermann, MT
    Odermatt, BF
    Briner, J
    Heitz, PU
    Zimmermann, DR
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1996, 44 (04) : 303 - 312
  • [8] IDENTIFICATION AND SYNTHESIS OF A RECOGNITION SIGNAL FOR THE ATTACHMENT OF GLYCOSAMINOGLYCANS TO PROTEINS
    BOURDON, MA
    KRUSIUS, T
    CAMPBELL, S
    SCHWARTZ, NB
    RUOSLAHTI, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (10) : 3194 - 3198
  • [9] Neurite outgrowth inhibitor of gliotic brain tissue. Mode of action and cellular localization, studied with specific monoclonal antibodies
    Bovolenta, P
    FernaudEspinosa, I
    MendezOtero, R
    NietoSampedro, M
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1997, 9 (05) : 977 - 989
  • [10] CHARACTERIZATION OF A NEURITE OUTGROWTH INHIBITOR EXPRESSED AFTER CNS INJURY
    BOVOLENTA, P
    WANDOSELL, F
    NIETOSAMPEDRO, M
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1993, 5 (05) : 454 - 465